Vitamin A derivative suppresses immune response and cancer vaccine efficacy
Inhibitors targeting retinoic acid production restore dendritic cell function, significantly enhancing cancer vaccine efficacy and immune response in preclinical mouse studies.
3 Articles
3 Articles
Vitamin A’s Dark Side: How a Common Nutrient Can Help Tumors Evade the Immune System
Scientists have uncovered how a vitamin A metabolite can suppress anti-cancer immunity. Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have uncovered new ways in which a vitamin A-derived molecule, all-trans retinoic acid, interferes with the immune system’s ability to fight cancer. Their work shows that this compound can weaken [...]
Vitamin A derivative suppresses immune response and cancer vaccine efficacy
Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by which a metabolic derivative of vitamin A-all-trans retinoic acid-compromises both the body's normal anti-cancer immune response and, in a different context, the efficacy of a promising type of cancer vaccine.
Blocking Retinoic Acid Pathway Improves Dendritic Cell Anti-Tumor Function
Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by which a metabolic derivative of vitamin A-all-trans retinoic acid-compromises both the body's normal anti-cancer immune response and, in a different context, the efficacy of a promising type of cancer vaccine.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium


